The feasibility of using Bone Morphogenetic Protein (rhBMP-7) for reconstruction of alveolar cleft - The use of BMP for alveolar reconstruction

HS Greater Glasgow/Glasgow University0 个研究点目标入组 30 人开始时间: 2006年1月13日最近更新: 2012年4月3日

试验速览

暂无简介。

•1. Patients require reconstruction of alveolar cleft.
•2. A full understanding of the aim of the study to the nature of the medicinal product.
•3. Age restriction is 8-14 years.
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1. Patients who are taking medication that has an effect on bone turnover such as calcitonin or steroids.
•2. Patients suffering from metabolic bone diseases.
•3. Patients with a known sensitivity to any component of Osigraft.
•4. Patients with immunosuppression.
•5. Patients with an active infection at or near the cleft.
•6. Patients with tumours at or near the cleft.

发起方

HS Greater Glasgow/Glasgow University